In Uncategorized On the Rise: Healthcare Private Equity Midyear Update August 16, 2023 No Comments Deal activity has picked up, with biopharma and Asia-Pacific deals posting the greatest gains. Author Related Posts AI memory is sold out, causing an unprecedented surge in prices January 11, 2026 Distressed M&A predicted to play a major role in European HealthTech and MedTech 2026 January 11, 2026 Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope January 11, 2026
Distressed M&A predicted to play a major role in European HealthTech and MedTech 2026 January 11, 2026
Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope January 11, 2026